Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Interest Expenses (2019 - 2025)

Rockwell Medical (RMTI) has disclosed Interest Expenses for 7 consecutive years, with $285000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses fell 5.63% year-over-year to $285000.0, compared with a TTM value of $1.1 million through Sep 2025, down 45.63%, and an annual FY2024 reading of $1.3 million, down 45.5% over the prior year.
  • Interest Expenses was $285000.0 for Q3 2025 at Rockwell Medical, up from $276000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.1 million in Q4 2023 and bottomed at $232000.0 in Q2 2024.
  • Average Interest Expenses over 5 years is $457578.9, with a median of $431000.0 recorded in 2024.
  • The sharpest move saw Interest Expenses surged 469.61% in 2021, then tumbled 73.92% in 2024.
  • Year by year, Interest Expenses stood at $588000.0 in 2021, then fell by 25.34% to $439000.0 in 2022, then skyrocketed by 152.39% to $1.1 million in 2023, then crashed by 73.92% to $289000.0 in 2024, then fell by 1.38% to $285000.0 in 2025.
  • Business Quant data shows Interest Expenses for RMTI at $285000.0 in Q3 2025, $276000.0 in Q2 2025, and $277000.0 in Q1 2025.